BioSpace News Archive

Wounded Warrior Project® shared how it is addressing post-traumatic stress disorder and traumatic brain injury – the signature wounds of the global war on terror – during Washington Post Live’s The Changing Face of American Veterans event.

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Ra Medical Systems, Inc. pursuant and/or traceable to the registration statement and prospectus issued in connection with Ra Medical’s September 2018 initial public offering.

Leveraging its rich history of providing surgeons and their patients dynamic visualization experiences in the clinic and throughout the treatment continuum, Surgical Theater is proud that the Precision VR® platform is being featured at the Transcatheter Valve Therapies (TVT) Structural Heart Summit’s Late-Breaking Science Sessions in Chicago, IL.

Amgen and Allergan plc announced that the U.S. Food and Drug Administration has approved KANJINTI™ for all approved indications of the reference product, Herceptin®: for the treatment of HER2-overexpressing adjuvant and metastatic breast cancer and HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.

CRH Medical Corporation, announces the following voting results for the Company’s 2019 Annual Meeting of Shareholders.

Seres Therapeutics, Inc. announced the pricing of an underwritten public offering of 26,666,667 shares of its common stock, at a public offering price of $2.25 per share, before underwriting discounts and commissions.

Cortellucci family makes historic $40-million donation to new Mackenzie Vaughan Hospital

In today’s world, the most popular technology is portable and usable on the go. Every year, while electronic products get smaller and smaller, it makes sense for consumers to move towards wearable technology.

Sareum Holdings plc (AIM: SAR), the specialist small molecule drug development business, follows the Company’s recent announcements on SRA737 with an update on other developments within its active preclinical portfolio.

Almac Clinical Services, part of the Almac Group, has today announced the launch of Almac Adapt™ - an innovative Just in Time Manufacturing (JTM) solution.